These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 12808311)

  • 1. Comparative study of protective effects of chitin, chitosan, and N-acetyl chitohexaose against Pseudomonas aeruginosa and Listeria monocytogenes infections in mice.
    Okawa Y; Kobayashi M; Suzuki S; Suzuki M
    Biol Pharm Bull; 2003 Jun; 26(6):902-4. PubMed ID: 12808311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective effect of N-acetyl chitohexaose on Listeria monocytogenes infection in mice.
    Tokoro A; Kobayashi M; Tatewaki N; Suzuki K; Okawa Y; Mikami T; Suzuki S; Suzuki M
    Microbiol Immunol; 1989; 33(4):357-67. PubMed ID: 2505022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protecting effect of chitin and chitosan on experimentally induced murine candidiasis.
    Suzuki K; Okawa Y; Hashimoto K; Suzuki S; Suzuki M
    Microbiol Immunol; 1984; 28(8):903-12. PubMed ID: 6094990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective effect of baker's yeast mannan against Listeria monocytogenes and Pseudomonas aeruginosa infection in mice.
    Kobayashi M; Okawa Y; Suzuki S; Suzuki M
    Chem Pharm Bull (Tokyo); 1990 Mar; 38(3):807-9. PubMed ID: 2189582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differing contribution of polymorphonuclear cells and macrophages to protection of mice against Listeria monocytogenes and Pseudomonas aeruginosa.
    Tatsukawa K; Mitsuyama M; Takeya K; Nomoto K
    J Gen Microbiol; 1979 Nov; 115(1):161-6. PubMed ID: 119029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective effect of Lactobacillus casei on Pseudomonas aeruginosa infection in mice.
    Miake S; Nomoto K; Yokokura T; Yoshikai Y; Mutai M; Nomoto K
    Infect Immun; 1985 May; 48(2):480-5. PubMed ID: 3921464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased delayed-type hypersensitivity and increased protection to Listeria monocytogenes seen in mice infected with mucoid and nonmucoid Pseudomonas aeruginosa.
    Blackwood LL
    Infect Immun; 1985 Mar; 47(3):840-2. PubMed ID: 3918939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral pretreatment of mice with CpG DNA reduces susceptibility to oral or intraperitoneal challenge with virulent Listeria monocytogenes.
    Ray NB; Krieg AM
    Infect Immun; 2003 Aug; 71(8):4398-404. PubMed ID: 12874318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vitamin A-induced nonspecific resistance to infection.
    Cohen BE; Elin RJ
    J Infect Dis; 1974 May; 129(5):597-600. PubMed ID: 4207311
    [No Abstract]   [Full Text] [Related]  

  • 10. Protective effect of saikosaponin A, saikosaponin D and saikogenin D against Pseudomonas aeruginosa infection in mice.
    Kumazawa Y; Kawakita T; Takimoto H; Nomoto K
    Int J Immunopharmacol; 1990; 12(5):531-7. PubMed ID: 2210914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunological activity of chitin and its derivatives.
    Nishimura K; Nishimura S; Nishi N; Saiki I; Tokura S; Azuma I
    Vaccine; 1984 Mar; 2(1):93-9. PubMed ID: 6397928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of N-acetylchito-oligosaccharides on activation of phagocytes.
    Suzuki K; Tokoro A; Okawa Y; Suzuki S; Suzuki M
    Microbiol Immunol; 1986; 30(8):777-87. PubMed ID: 3784930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The protective effects of nasal PcrV-CpG oligonucleotide vaccination against Pseudomonas aeruginosa pneumonia.
    Naito Y; Hamaoka S; Kinoshita M; Kainuma A; Shimizu M; Katoh H; Moriyama K; Ishii KJ; Sawa T
    Microbiol Immunol; 2018 Dec; 62(12):774-785. PubMed ID: 30378708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohematopoietic modulation by oral β-1,3-glucan in mice infected with Listeria monocytogenes.
    Torello CO; de Souza Queiroz J; Oliveira SC; Queiroz ML
    Int Immunopharmacol; 2010 Dec; 10(12):1573-9. PubMed ID: 20951668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD40 signaling converts a minimally immunogenic antigen into a potent vaccine against the intracellular pathogen Listeria monocytogenes.
    Rolph MS; Kaufmann SH
    J Immunol; 2001 Apr; 166(8):5115-21. PubMed ID: 11290793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective activity of thymosin against opportunistic infections in animal models.
    Ishitsuka H; Umeda Y; Nakamura J; Yagi Y
    Cancer Immunol Immunother; 1983; 14(3):145-50. PubMed ID: 6404549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chitin Oligosaccharide Modulates Gut Microbiota and Attenuates High-Fat-Diet-Induced Metabolic Syndrome in Mice.
    Zheng J; Cheng G; Li Q; Jiao S; Feng C; Zhao X; Yin H; Du Y; Liu H
    Mar Drugs; 2018 Feb; 16(2):. PubMed ID: 29463060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic 70% deacetylated chitin (DAC-70) as a treatment for MRL/1pr murine lupus; reduction of immunoglobulin deposition in the skin and kidneys.
    Horiuchi Y; Tsurutani R; Kifune K
    J Dermatol; 1997 Jan; 24(1):63-5. PubMed ID: 9046746
    [No Abstract]   [Full Text] [Related]  

  • 19. BCG-induced susceptibility of mice to challenge with Pseudomonas aeruginosa.
    Lal S; Mitsuyama M; Ogata N; Miyata M; Miake S; Nomoto K
    J Gen Microbiol; 1983 Jan; 129(1):93-8. PubMed ID: 6403661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Class Ia MHC-deficient BALB/c mice generate CD8+ T cell-mediated protective immunity against Listeria monocytogenes infection.
    D'Orazio SE; Halme DG; Ploegh HL; Starnbach MN
    J Immunol; 2003 Jul; 171(1):291-8. PubMed ID: 12817010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.